These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8758529)

  • 1. [Renal tolerability of cisplatin].
    Escudier B
    Rev Med Interne; 1996; 17(6):450-1. PubMed ID: 8758529
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity.
    El-Arabey AA
    Pharmacol Res; 2017 May; 119():493. PubMed ID: 27890551
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation in cisplatin nephropathy.
    Tamano M; Ohi H
    Nephron; 1999; 81(4):442-3. PubMed ID: 10095183
    [No Abstract]   [Full Text] [Related]  

  • 4. C-Phycocyanin attenuates cisplatin-induced nephrotoxicity in mice.
    Nasri H
    Ren Fail; 2013 Aug; 35(7):1054-5. PubMed ID: 23826855
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.
    Launay-Vacher V; Rey JB; Isnard-Bagnis C; Deray G; Daouphars M;
    Cancer Chemother Pharmacol; 2008 May; 61(6):903-9. PubMed ID: 18317762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to the letter addressed by Amr A. EL-Arabey "Dual function of OCT-2 and MATE1 in Cisplatin induced nephrotoxicity".
    Thomas F
    Pharmacol Res; 2017 May; 119():494. PubMed ID: 27890819
    [No Abstract]   [Full Text] [Related]  

  • 7. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
    Goligorsky MS
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
    [No Abstract]   [Full Text] [Related]  

  • 8. Cisplatin nephropathy: is cytotoxicity avoidable?
    Razzaque MS
    Nephrol Dial Transplant; 2007 Aug; 22(8):2112-6. PubMed ID: 17617652
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrolyte Abnormalities in Cisplatin Based Chemotherapy.
    Nikhil S; Anand AS
    Indian J Physiol Pharmacol; 2016; 60(3):298-99. PubMed ID: 29957986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nephrotoxicity of antineoplastic drugs].
    Suzuki T; Nosaka K
    Ryoikibetsu Shokogun Shirizu; 1997; (16 Pt 1):542-6. PubMed ID: 9277811
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium-wasting nephropathy caused by cisplatin in esophageal cancer.
    Abdelghani L; Modha K; Albaddawi E; Subramanian S
    J Support Oncol; 2008; 6(7):305-6. PubMed ID: 18847072
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisplatin-associated nephrotoxicity and pathological events.
    Taguchi T; Nazneen A; Abid MR; Razzaque MS
    Contrib Nephrol; 2005; 148():107-121. PubMed ID: 15912030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Goren MP
    Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renal toxicity of cancer chemotherapeutic agents.
    Weiss RB; Poster DS
    Cancer Treat Rev; 1982 Mar; 9(1):37-56. PubMed ID: 6175410
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of hydrogen sulphide formation reduces cisplatin-induced renal damage.
    Della Coletta Francescato H; Cunha FQ; Costa RS; Barbosa Júnior F; Boim MA; Arnoni CP; da Silva CG; Coimbra TM
    Nephrol Dial Transplant; 2011 Feb; 26(2):479-88. PubMed ID: 20656754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amifostine protects against cisplatin-induced nephrotoxicity in a child with medulloblastoma.
    Hayek M; Srinivasan A
    Pediatr Hematol Oncol; 2003; 20(3):253-6. PubMed ID: 12637222
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse effects of cytotoxics-platinum agents.
    Selvaratnam G; Philips RH; Mohamed AK; Radzi A
    Adverse Drug React Toxicol Rev; 1997 Aug; 16(3):171-97. PubMed ID: 9512763
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytostatics--induced tubular toxicity.
    Brandis M; von der Hardt K; Zimmerhackl RB; Mohrmann M; Leititis J
    Clin Investig; 1993 Oct; 71(10):855-7. PubMed ID: 8305848
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.
    Ries F; Klastersky J
    Am J Kidney Dis; 1986 Nov; 8(5):368-79. PubMed ID: 3538860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cisplatin-induced renal salt wasting syndrome.
    Hamdi T; Latta S; Jallad B; Kheir F; Alhosaini MN; Patel A
    South Med J; 2010 Aug; 103(8):793-9. PubMed ID: 20622742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.